Monitoring includes regular assessment of weight, vital signs, medication tolerance, complete blood count, comprehensive metabolic panel, renal function, and nutritional parameters including vitamin B12, folate, iron, vitamin D, calcium, and protein status
90% of the people with Type 2 diabetes are either overweight or obese
Integrating genetic insights, biomarker assessment, clinical history, and real-world tolerability data supports a more comprehensive provider conversation about whether semaglutide, tirzepatide, or a dual-compound option like GLP-Squared may align best with your health profile and treatment goals
This narrative approach allowed for comprehensive synthesis of current evidence while maintaining the flexibility to include diverse study designs and clinical perspectives relevant to understanding all aspects of DPN
Some patients report improved bloating or reduced abdominal discomfort